Former NYC Health Commissioner Dr. Ashwin Vasan explores what Trump’s nominations of RFK Jr. and David Weldon mean for health ...

Fourteen members of a small religious sect in Australia have been found guilty of the manslaughter of an 8-year-old girl, who ...

Nearly half of Type 2 diabetes patients suffer from micronutrient deficiencies, with vitamin D and magnesium being the most ...

BMO Capital Markets affirmed their positive stance on Novo Nordisk (NYSE:NVO) shares, maintaining an Outperform rating and a $105.00 price target. This confirmation followed the U.S. Food and Drug ...

Micronutrient deficiencies, such as low vitamin D and magnesium, are alarmingly common in people with type 2 diabetes, ...

A positive response to treatment for pediatric obesity has enduring health benefits into young adulthood, according t ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...

Managing type 2 diabetes involves complex treatment, workload, and costs that impose a significant burden on individuals, ...

Findings indicate a 12.8% 10-year diabetes risk, driven by fasting plasma glucose, age, sex, and BMI, highlighting the need ...